Glucose Metabolism Disorders
Pathological conditions in which the BLOOD GLUCOSE cannot be maintained within the normal range, such as in HYPOGLYCEMIA and HYPERGLYCEMIA. Etiology of these disorders varies. Plasma glucose concentration is critical to survival for it is the predominant fuel for the CENTRAL NERVOUS SYSTEM.
Subtype terms (5)
More specific conditions that are subtypes of Glucose Metabolism Disorders in the MeSH hierarchy.
- Diabetes Mellitus
899 drugs (388 approved, 511 experimental)
- Glycosuria
- Hyperglycemia
179 drugs (65 approved, 114 experimental)
- Hyperinsulinism
31 drugs (24 approved, 7 experimental)
- Hypoglycemia
106 drugs (68 approved, 38 experimental)
Drugs by status
Phase 4 trials (20)
Phase 3 trials (13)
Phase 2 trials (14)
Phase 1 trials (6)
Other trials (41)
- maltodextrin
- iron
- olbetam
- agave
- vitamin e
- berberine
- cranberry
- fiber
- somatropin
- gip (1-42)
- liraglutide
- glucagon like peptide-2
- l-glutamine
- nevulose
- whey protein
- semaglutide
- aliskiren
- exendin (9-39)
- tumor necrosis factor
- spironolactone
- endotoxin
- glucagon
- glucagon-like peptide-1
- hazelnut, unspecified
- akkermansia muciniphila
- lupin protein
- sucralose
- amino acids
- methaqualone
- acesulfame potassium
- +11 more
Organizations
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (13)
Organization Involved with Phase 2 Indications (25)
- Diamyd
- Stem Cells Arabia
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute of Neurological Disorders and Stroke (NINDS)
- Aarhus University
- Cairo University
- Institut National de la Santé Et de la Recherche Médicale, France
- University of Glasgow
- University of Oslo
- University of Copenhagen
- Uppsala University
- Vanderbilt University
- University of Basel
- University of Gothenburg
- Linkoping University
- South-Eastern Norway Regional Health Authority
- Norwegian Diabetes Association
- Government of Norway
- Vestre Viken Ringerike Sykehus
- Yeshiva University
- University of Grenoble
- Oslo Metropolitan University
- The University of Texas, Dallas
- King Abdul-Aziz University
Organization Involved with Other Experimental Indications (34)
- Atrium Innovations
- Maastricht University
- Centre National d'Etudes Spatiales
- Chang Gung University
- University of London
- DLR German Aerospace Center
- German Institute of Human Nutrition
- Osaka University
- Thomas Jefferson University
- University of Milan
- University of Aberdeen
- Laval University
- Peking University
- Purdue University
- Université catholique de Louvain
- University of Missouri
- Charles University
- Humboldt University
- University of Tuebingen
- DIANA Food
- Almond Board of California
- Soremartec Italia S.r.l.
- Danish Council for Independent Research
- Lundbeck
- German Diabetes Foundation, Munich, Germany
- Klinikum Ernst von Bergmann Augenklinik Laserzentrum
- Pharmalogica
- Wearnes Biotech and Medicals
- Government of Quebec
- Nestle
- +4 more